The Antioxidant Tetrapeptide Epitalon Enhances Delayed Wound Healing in an in Vitro Model of Diabetic Retinopathy.

This is a source-metadata record last found in a complete check on Sep 25, 2026. It is not a Pependium assessment of safety or effectiveness. Check the original sources for current details, corrections and full methods.

Source status: Exact-ID Europe PMC status checked Sep 25, 2026. No retraction or correction publication-type marker was listed in that response. This does not rule out other updates.

Study metadata

Study type: Original study
Study category (metadata hint): Cell or laboratory
Published: 2025-06-10
Authors: Gatta M, Dovizio M, Milillo C, Ruggieri AG, Sallese M, Antonucci I, Trofimov A, Khavinson V
Journal or registry: Stem cell reviews and reports
Registry study design: Not reported
Registry enrollment: Not reported
Funding agencies: European Union—Next Generation EU—under the National Recovery and Resilience Plan; European Union-Next Generation EU-under the National Recovery and Resilience Plan (NRRP)
Identifiers: DOI: 10.1007/s12015-025-10911-x · PMID: 40493162 · PMCID: PMC12356729
First found: Sep 24, 2026
Last found: Sep 25, 2026

Original sources

View at Europe PMC ↗View at PubMed ↗